You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Mineralocorticoid Receptor antibody (ab62532)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Mineralocorticoid Receptor antibody
See all Mineralocorticoid Receptor products (5) ...

Description

Rabbit polyclonal to Mineralocorticoid Receptor

Tested applications

WB, IHC-Pmore details

Cross reactivity

Reacts with

Human

Predicted to work with

Mouse, Rat, Chicken

Immunogen

A region within synthetic peptide: KIRRKNCPAC RLQKCLQAGM NLGARKSKKL GKLKGIHEEQ PQQQQPPPPP, corresponding to internal sequence amino acids 649-698 of Human Mineralocorticoid Receptor

KIRRKNCPAC RLQKCLQAGM NLGARKSKKL GKLKGIHEEQ PQQQQPPPPP

Positive control

A172 cell lysate. Human kidney tissue.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: None
Constituents: 2% Sucrose, PBS

Concentration

Concentration information loading...

Purity

Protein A purified

Clonality

Polyclonal

Isotype

IgG

  • Western blot - Mineralocorticoid Receptor antibody (ab62532)Western blot - Mineralocorticoid Receptor antibody (ab62532) image (enlarge)

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Mineralocorticoid Receptor antibody (ab62532)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Mineralocorticoid Receptor antibody (ab62532) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab62532 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Receptor for both mineralocorticoids (MC) such as aldosterone and glucocorticoids (GC) such as corticosterone or cortisol. Binds to mineralocorticoid response elements (MRE) and transactivates target genes. The effect of MC is to increase ion and water transport and thus raise extracellular fluid volume and blood pressure and lower potassium levels.

Tissue specificity

Ubiquitous. Highly expressed in distal tubules, convoluted tubules and cortical collecting duct in kidney, and in sweat glands. Detected at lower levels in cardiomyocytes, in epidermis and in colon enterocytes.

Involvement in disease

Defects in NR3C2 are a cause of autosomal dominant pseudohypoaldosteronism type I (AD-PHA1) [MIM:177735]. PHA1 is characterized by urinary salt wasting, resulting from target organ unresponsiveness to mineralocorticoids. There are 2 forms of PHA1: the autosomal dominant form that is mild, and the recessive form which is more severe and due to defects in any of the epithelial sodium channel subunits. In AD-PHA1 the target organ defect is confined to kidney. Clinical expression can vary from asymptomatic to moderate. It may be severe at birth, but symptoms remit with age. Familial and sporadic cases have been reported.
Defects in NR3C2 are a cause of early-onset hypertension with severe exacerbation in pregnancy (EOHSEP) [MIM:605115]. Inheritance is autosomal dominant. The disease is characterized by the onset of severe hypertension before the age of 20, and by suppression of aldosterone secretion.

Sequence similarities

Belongs to the nuclear hormone receptor family. NR3 subfamily.
Contains 1 nuclear receptor DNA-binding domain.

Domain

Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain.

Post-translational
modifications

Phosphorylated.

Cellular localization

Cytoplasm. Nucleus. Endoplasmic reticulum membrane. Cytoplasmic and nuclear in the absence of ligand; nuclear after ligand-binding. When bound to HSD11B2, it is found associated with the endoplasmic reticulum membrane.

Target information above from: UniProt accessionP08235 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Aldosterone receptor antibody
  • MCR antibody
  • MCR_HUMAN antibody
  • MGC133092 antibody
  • Mineralocorticoid receptor antibody
  • MLR antibody
  • MR antibody
  • NR3 C2 antibody
  • NR3C2 antibody
  • NR3C2 protein antibody
  • Nuclear receptor subfamily 3 group C member 2 antibody
see all

Anti-Mineralocorticoid Receptor antibody images:

  Western blot - Mineralocorticoid Receptor antibody (ab62532)

Western blot - Mineralocorticoid Receptor antibody (ab62532)

Anti-Mineralocorticoid Receptor antibody (ab62532) at 1.25 µg/ml + A172 cell lysate at 10 µg

Secondary
HRP conjugated anti-Rabbit IgG at 1/50000 dilution

Predicted band size : 107 kDa
Observed band size : 90 kDa (why is the actual band size different from the predicted?)


Gel concentration: 8%

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Mineralocorticoid Receptor antibody (ab62532)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Mineralocorticoid Receptor antibody (ab62532)

ab62532 (4-8ug/ml) staining Mineralocorticoid Receptor in human kidney tissue by immunohistochemistry using paraffin-embedded tissue. The arrows indicate positively stained epithelial cells of the renal tubule.

References for Anti-Mineralocorticoid Receptor antibody (ab62532)

ab62532 has not yet been referenced specifically in any publications.

Publishing research using ab62532? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"